Eurotrials provides an extensive array of drug development services, from early- to late-stage as well as product support in accordance with global and specific regional requirements. Innovative models of collaboration with the biopharmaceutical and medical device industry, research institutions and clinical research sites are the main drivers of Eurotrials’ development strategy.

Eurotrials has offices in Portugal, Spain, Brazil, Argentina, Chile and Mexico and presence in Peru, Colombia and several other European countries. The company has been validated by international biopharmaceutical companies, has several master agreements and is ISO- 9001 certified.